The aerobic decomposition of 3,4′,7-O-trialkylquercetins was first reported in this paper. The structures of four new decomposed products were characterized by analyzing the 1D and 2D NMR data, as well as their high resolution mass spectroscopic data. Their antiproliferative activity toward human prostate cancer cells has been assessed through WST-1 cell proliferation assay. The decomposition mechanism was also proposed.
SampsonL., RimmE., HollmanP.C., de VriesJ.H., KatanM.B. (2002) Flavonol and flavone intakes in US health professionals. Journal of the American Dietetic Association, 102, 1414–1420.
2.
BritoA.F., RibeiroM., AbrantesA.M., PiresA.S., TeixoR.J., TralhaoJ.G., BotelhoM.F. (2015) Quercetin in cancer treatment, alone or in combination with conventional therapeutics?Current Medicinal Chemistry, 22, 3025–3039.
3.
YangF., SongL., XingN., WangH., WangJ., XuZ. (2015) Quercetin in prostate cancer: chemotherapeutic and chemopreventive effects, mechanisms and clinical applicaton potential. Oncology Reports, 33, 2659–2668.
4.
VueB., ZhangS., ChenQ-H. (2015) Synergistic effects of dietary natural products as anti-prostate cancer agents. Natural Product Communications, 10, 2179–2188.
5.
VueB., ZhangS., ChenQ-H. (2015) Flavonoids with therapeutic potential in prostate cancer. Anti-Cancer Agents in Medicinal Chemistry, DOI: 10.2174/1871520615666151008122622
6.
CaiX., FangZ., DouJ., YuA., ZhaiG. (2013) Bioavailability of quercetin: problems and promises. Current Medicinal Chemistry, 20, 2572–2582.
7.
BeutlerJ.A., HamelE., VlietinckA.J., HaemersA., RajanP., RoitmanJ.N., CardellinaJ.H.2nd, BoydM.R. (1998) Structure-activity requirements for flavone cytotoxicity and binding to tubulin. Journal of Medicinal Chemistry, 41, 2333–2338.
8.
Al-JabbanS.M.R., ZhangX., ChenG., MekuriaE.A., RakotondraibeL.H., ChenQ-H. (2015) Synthesis and anti-proliferative effects of quercetin derivatives. Natural Product Communications, 10, 2113–2118.
9.
ShiZ-H, LiN-G, TangY-P, ShiQ-P, ZhangW., ZhangP-X, DongZ-X, LiW., ZhangX., FuH-A, DuanJ-A. (2014) Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. Bioorganic & Medicinal Chemistry Letters, 24, 4424–4427.
10.
RaoK.V., OwoyaleJ.A. (1976) Partial methylation of quercetin: direct synthesis of tamarixetin, ombuin and ayanin. Heterocyclic Chemistry, 13, 1293–1295.
11.
BouktaibM., LebrunS., AtmaniA., RolandoC. (2002) Hemisynthesis of all the O-monomethylated analogues of quercetin including the major metabolites, through selective protection of phenolic functions. Tetrahedron, 58, 10001–10009.
12.
ShiZ-H, LiN-G, TangY-P, WeiL., LianY., YangJ-P, HaoT., DuanJ-A. (2012) Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. European Journal of Medicinal Chemistry, 54, 210–222.
13.
FahlmanB.M., KrolE.S. (2009) UVA and UVB radiation-induced oxidation products of quercetin. Journal of Photochemistry and Photobiology, B: Biology, 97, 123–131.
14.
HiroseY., FujitaT., MatsugoS. (2001) Oxidative Products from quercetin during lipid peroxidation. ITE Letters on Batteries, New Technologies & Medicine, 2, 825–828.
15.
KrishnamachariV., LevineL.H., PareP.W. (2002) Flavonoid oxidation by the radical generator AIBN: a unified mechanism for quercetin radical scavenging. Journal of Agricultural and Food Chemistry, 50, 4357–4363.
